Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multigene panels in prostate cancer risk assessment: a systematic review.

Genetics in medicine : official journal of the American College of Medical Genetics - 1 Jun 2016

Little Julian, Wilson Brenda, Carter Ron, Walker Kate, Santaguida Pasqualina, Tomiak Eva, Beyene Joseph, Usman Ali Muhammad, Raina Parminder

Abstract excerpt

PURPOSE: Single-nucleotide polymorphism (SNP) panel tests have been proposed for use in the detection of, and prediction of risk for, prostate cancer and as prognostic indicator in affected men. A systematic review was undertaken to address three research questions to evaluate the analytic validity, clinical validity, clinical utility, and prognostic validity of SNP-based panels. METHODS: Data sources comprised...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Polymorphism, Single Nucleotide

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prognosis

Share to Prostatic Neoplasms

Share to Risk Assessment

Source

Identifiers

PMID: 26426883
DOI: 10.1038/gim.2015.125

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multigene panels in prostate cancer risk assessment: a systematic review.PMID 26426883Read ↗

Multigene panels in prostate cancer risk assessment.Semantic proximity Read ↗

Clinical validity and utility of genetic risk scores in prostate cancer.Semantic proximity Read ↗

A genetic-based approach to personalized prostate cancer screening and treatment.Semantic proximity Read ↗

Does genotyping of risk-associated single nucleotide polymorphisms improve patient selection for prostate biopsy when combined with a prostate cancer risk calculator?Semantic proximity Read ↗

The role of single nucleotide polymorphisms in predicting prostate cancer risk and therapeutic decision making.Semantic proximity Read ↗

Comprehensive Analysis of Multiple Cohort Datasets Deciphers the Utility of Germline Single-Nucleotide Polymorphisms in Prostate Cancer Diagnosis.Semantic proximity Read ↗

Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer.Semantic proximity Read ↗

When is a genetic test suitable for prime time? Predicting the risk of prostate cancer as a case-example.Semantic proximity Read ↗

Validation of a prostate cancer polygenic risk score.Semantic proximity Read ↗

Polygenic risk score improves prostate cancer risk prediction: results from the Stockholm-1 cohort study.Semantic proximity Read ↗

Performance of Three Inherited Risk Measures for Predicting Prostate Cancer Incidence and Mortality: A Population-based Prospective Analysis.Semantic proximity Read ↗

A comparison of genetic risk score with family history for estimating prostate cancer risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.